403 related articles for article (PubMed ID: 27007719)
1. The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.
Griffin TP; Martin WP; Islam N; O'Brien T; Griffin MD
Curr Diab Rep; 2016 May; 16(5):42. PubMed ID: 27007719
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect of mesenchymal stem cells in diabetic kidney disease.
Habiba UE; Khan N; Greene DL; Shamim S; Umer A
J Mol Med (Berl); 2024 Apr; 102(4):537-570. PubMed ID: 38418620
[TBL] [Abstract][Full Text] [Related]
3. Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy.
Li H; Rong P; Ma X; Nie W; Chen C; Yang C; Zhang J; Dong Q; Wang W
Life Sci; 2018 Dec; 215():113-118. PubMed ID: 30399376
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic role of mesenchymal stem cells (MSCs) in diabetic kidney disease (DKD).
Xu N; Liu J; Li X
Endocr J; 2022 Oct; 69(10):1159-1172. PubMed ID: 35858781
[TBL] [Abstract][Full Text] [Related]
5. Progress toward the Clinical Application of Mesenchymal Stromal Cells and Other Disease-Modulating Regenerative Therapies: Examples from the Field of Nephrology.
Hickson LJ; Herrmann SM; McNicholas BA; Griffin MD
Kidney360; 2021 Mar; 2(3):542-557. PubMed ID: 34316720
[TBL] [Abstract][Full Text] [Related]
6. An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease.
Lin Y; Yang Q; Wang J; Chen X; Liu Y; Zhou T
Front Endocrinol (Lausanne); 2022; 13():962635. PubMed ID: 35966088
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy.
Hamza AH; Al-Bishri WM; Damiati LA; Ahmed HH
Ren Fail; 2017 Nov; 39(1):67-76. PubMed ID: 27774826
[TBL] [Abstract][Full Text] [Related]
8. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
[TBL] [Abstract][Full Text] [Related]
9. Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells.
Bian X; Conley SM; Eirin A; Zimmerman Zuckerman EA; Smith AL; Gowan CC; Snow ZK; Jarmi T; Farres H; Erben YM; Hakaim AG; Dietz MA; Zubair AC; Wyles SP; Wolfram JV; Lerman LO; Hickson LJ
Stem Cell Res Ther; 2023 Mar; 14(1):49. PubMed ID: 36949528
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis of cell-based interventions in experimental diabetic kidney disease.
Hickson LJ; Abedalqader T; Ben-Bernard G; Mondy JM; Bian X; Conley SM; Zhu X; Herrmann SM; Kukla A; Lorenz EC; Kim SR; Thorsteinsdottir B; Lerman LO; Murad MH
Stem Cells Transl Med; 2021 Sep; 10(9):1304-1319. PubMed ID: 34106528
[TBL] [Abstract][Full Text] [Related]
11. Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus.
Ezquer F; Giraud-Billoud M; Carpio D; Cabezas F; Conget P; Ezquer M
Biomed Res Int; 2015; 2015():164703. PubMed ID: 26167475
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Mesenchymal Stem Cells in a Pre-Clinical Model of Diabetic Kidney Disease and Obesity.
Sávio-Silva C; Soinski-Sousa PE; Simplício-Filho A; Bastos RMC; Beyerstedt S; Rangel ÉB
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557007
[TBL] [Abstract][Full Text] [Related]
13. Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis.
Lin W; Li HY; Yang Q; Chen G; Lin S; Liao C; Zhou T
Stem Cell Res Ther; 2021 Jan; 12(1):43. PubMed ID: 33413678
[TBL] [Abstract][Full Text] [Related]
14. The Multi-Therapeutic Role of MSCs in Diabetic Nephropathy.
Wang Y; Shan SK; Guo B; Li F; Zheng MH; Lei LM; Xu QS; Ullah MHE; Xu F; Lin X; Yuan LQ
Front Endocrinol (Lausanne); 2021; 12():671566. PubMed ID: 34163437
[TBL] [Abstract][Full Text] [Related]
15. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?
Griffin MD; Elliman SJ; Cahill E; English K; Ceredig R; Ritter T
Stem Cells; 2013 Oct; 31(10):2033-41. PubMed ID: 23766124
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells.
Sávio-Silva C; Beyerstedt S; Soinski-Sousa PE; Casaro EB; Balby-Rocha MTA; Simplício-Filho A; Alves-Silva J; Rangel ÉB
Stem Cells Int; 2020; 2020():8833725. PubMed ID: 33505469
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors.
Bell GI; Meschino MT; Hughes-Large JM; Broughton HC; Xenocostas A; Hess DA
Stem Cells Dev; 2012 Jul; 21(11):1863-76. PubMed ID: 22309189
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes.
Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Konari N; Fujimiya M
Sci Rep; 2016 Oct; 6():34842. PubMed ID: 27721418
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy.
Rashed LA; Elattar S; Eltablawy N; Ashour H; Mahmoud LM; El-Esawy Y
Biochem Cell Biol; 2018 Oct; 96(5):564-571. PubMed ID: 29425466
[TBL] [Abstract][Full Text] [Related]
20. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
